Literature DB >> 29496786

Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.

Kyle T S Pattinson1,2, Matthew J Rowland3,2, Annabel H Nickol4, Jane Quinlan3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29496786     DOI： 10.1183/13993003.02531-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding.

Authors:  Jan-Marino Ramirez; Nicholas J Burgraff; Aguan D Wei; Nathan A Baertsch; Adrienn G Varga; Helen A Baghdoyan; Ralph Lydic; Kendall F Morris; Donald C Bolser; Erica S Levitt
Journal:  J Neurophysiol       Date:  2021-04-07       Impact factor: 2.714

2.  Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature.

Authors:  François Blumenfeld-Kouchner; Lisa Bullis; Kathy Koch
Journal:  Palliat Med Rep       Date:  2021-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.